- A new biological marker in inflammatory bowel disease: Pentraxin 3
Semih KALYON et al, 2020, Journal of Surgery and Medicine CrossRef - The pentraxin family in autoimmune disease
Yongzhen Li et al, 2023, Clinica Chimica Acta CrossRef - Clinical Significance of CD147 in Children with Inflammatory Bowel Disease
Hongli Wang et al, 2020, BioMed Research International CrossRef - Pentraxin 3: A promising therapeutic target for autoimmune diseases
Qian Wu et al, 2020, Autoimmunity Reviews CrossRef - Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
Hao Zhang et al, 2022, Biomedicine & Pharmacotherapy CrossRef - Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease
Aleksandra Kałużna et al, 2023, Biomolecules CrossRef - Therapeutic effects of vitamin D on acetic acid-induced colitis in rats
Refik Bademci et al, 2020, Acta Cirúrgica Brasileira CrossRef - Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
Eleonora Gaetani et al, 2018, International Journal of Molecular Sciences CrossRef